The European Medicines Agency’s Committee for Medicinal Products for Human Use has granted a positive opinion for the use of Veklury (remdesivir) in COVID-19 patients with severe renal impairment, including those undergoing dialysis. This decision, subject to review by the European Commission (EC), could make remdesivir the first authorised antiviral ...
COVID-19: Europe Recommends Veklury for Patients with Severe Renal Impairment
Deepa Varma | Medical News | 26 May 2023
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.Create a Free Account I have an account